Skip to content

Clinical trials

Atherosclerosis trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Switzerland Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20073
20112
20123
20132
20141
20165
20183
20201
20221
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting3
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Insel Gruppe AG, University Hospital Bern3
Amgen2
Biotronik AG2
University of Zurich2
Abbott Medical Devices1
AstraZeneca1
Bayer1
Boston Scientific Corporation1
CSL Behring1
Calmy Alexandra1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis27
Coronary Artery Disease9
Cardiovascular Diseases7
Peripheral Arterial Disease5
Heart Failure3
Acute Coronary Syndrome2
Coronary Stenosis2
Dyslipidemias2
Myocardial Infarction2
Obesity2

Trials

Showing 26 to 27 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.